
### [MONDO:0008977](http://purl.obolibrary.org/obo/MONDO_0008977)
**Label:** chondrosarcoma (disease)

**Subclasses:** [MONDO:0000515](http://purl.obolibrary.org/obo/MONDO_0000515) (bone chondrosarcoma), [MONDO:0003899](http://purl.obolibrary.org/obo/MONDO_0003899) (adult myxoid chondrosarcoma), [MONDO:0003898](http://purl.obolibrary.org/obo/MONDO_0003898) (pediatric myxoid chondrosarcoma), [MONDO:0003684](http://purl.obolibrary.org/obo/MONDO_0003684) (clear cell chondrosarcoma), [MONDO:0006853](http://purl.obolibrary.org/obo/MONDO_0006853) (mesenchymal chondrosarcoma), [MONDO:0005013](http://purl.obolibrary.org/obo/MONDO_0005013) (dedifferentiated chondrosarcoma), [MONDO:0003043](http://purl.obolibrary.org/obo/MONDO_0003043) (extraskeletal mesenchymal chondrosarcoma), [MONDO:0003682](http://purl.obolibrary.org/obo/MONDO_0003682) (localized chondrosarcoma), [MONDO:0003042](http://purl.obolibrary.org/obo/MONDO_0003042) (adult mesenchymal chondrosarcoma), [MONDO:0003683](http://purl.obolibrary.org/obo/MONDO_0003683) (juxtacortical chondrosarcoma), [MONDO:0003680](http://purl.obolibrary.org/obo/MONDO_0003680) (periosteal chondrosarcoma), [MONDO:0003044](http://purl.obolibrary.org/obo/MONDO_0003044) (extraosseous chondrosarcoma), [MONDO:0003681](http://purl.obolibrary.org/obo/MONDO_0003681) (myxoid chondrosarcoma), [MONDO:0003041](http://purl.obolibrary.org/obo/MONDO_0003041) (pediatric mesenchymal chondrosarcoma), [MONDO:0004391](http://purl.obolibrary.org/obo/MONDO_0004391) (adult extraosseous chondrosarcoma), [MONDO:0004392](http://purl.obolibrary.org/obo/MONDO_0004392) (intracranial chondrosarcoma), [MONDO:0012825](http://purl.obolibrary.org/obo/MONDO_0012825) (extraskeletal myxoid chondrosarcoma), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:1903204](http://purl.obolibrary.org/obo/GO_1903204) (negative regulation of oxidative stress-induced neuron death), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0043303](http://purl.obolibrary.org/obo/GO_0043303) (mast cell degranulation), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:1903208](http://purl.obolibrary.org/obo/GO_1903208) (negative regulation of hydrogen peroxide-induced neuron death), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0071376](http://purl.obolibrary.org/obo/GO_0071376) (cellular response to corticotropin-releasing hormone stimulus), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0010613](http://purl.obolibrary.org/obo/GO_0010613) (positive regulation of cardiac muscle hypertrophy), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0032765](http://purl.obolibrary.org/obo/GO_0032765) (positive regulation of mast cell cytokine production), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0045333](http://purl.obolibrary.org/obo/GO_0045333) (cellular respiration), [GO:0009444](http://purl.obolibrary.org/obo/GO_0009444) (pyruvate oxidation), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:1900625](http://purl.obolibrary.org/obo/GO_1900625) (positive regulation of monocyte aggregation), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0001046](http://purl.obolibrary.org/obo/GO_0001046) (core promoter sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0038097](http://purl.obolibrary.org/obo/GO_0038097) (positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048660](http://purl.obolibrary.org/obo/GO_0048660) (regulation of smooth muscle cell proliferation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0046321](http://purl.obolibrary.org/obo/GO_0046321) (positive regulation of fatty acid oxidation), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0071870](http://purl.obolibrary.org/obo/GO_0071870) (cellular response to catecholamine stimulus), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:2000253](http://purl.obolibrary.org/obo/GO_2000253) (positive regulation of feeding behavior), [GO:0035259](http://purl.obolibrary.org/obo/GO_0035259) (glucocorticoid receptor binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0061469](http://purl.obolibrary.org/obo/GO_0061469) (regulation of type B pancreatic cell proliferation), [GO:0007369](http://purl.obolibrary.org/obo/GO_0007369) (gastrulation), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:2000108](http://purl.obolibrary.org/obo/GO_2000108) (positive regulation of leukocyte apoptotic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:2000505](http://purl.obolibrary.org/obo/GO_2000505) (regulation of energy homeostasis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0035726](http://purl.obolibrary.org/obo/GO_0035726) (common myeloid progenitor cell proliferation), 

**Class expressions from DL-Learner:**

- [GO:0038097](http://purl.obolibrary.org/obo/GO_0038097) (positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway) 52.94%
- [GO:0035726](http://purl.obolibrary.org/obo/GO_0035726) (common myeloid progenitor cell proliferation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0050867](http://purl.obolibrary.org/obo/GO_0050867) (positive regulation of cell activation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0050865](http://purl.obolibrary.org/obo/GO_0050865) (regulation of cell activation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0048522](http://purl.obolibrary.org/obo/GO_0048522) (positive regulation of cellular process) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0038095](http://purl.obolibrary.org/obo/GO_0038095) (Fc-epsilon receptor signaling pathway) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0033005](http://purl.obolibrary.org/obo/GO_0033005) (positive regulation of mast cell activation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0033003](http://purl.obolibrary.org/obo/GO_0033003) (regulation of mast cell activation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0002696](http://purl.obolibrary.org/obo/GO_0002696) (positive regulation of leukocyte activation) 52.94%
- [GO:0002431](http://purl.obolibrary.org/obo/GO_0002431) (Fc receptor mediated stimulatory signaling pathway) and [GO:0002694](http://purl.obolibrary.org/obo/GO_0002694) (regulation of leukocyte activation) 52.94%
- [GO:0002429](http://purl.obolibrary.org/obo/GO_0002429) (immune response-activating cell surface receptor signaling pathway) and [GO:0050867](http://purl.obolibrary.org/obo/GO_0050867) (positive regulation of cell activation) 52.94%
- [GO:0002429](http://purl.obolibrary.org/obo/GO_0002429) (immune response-activating cell surface receptor signaling pathway) and [GO:0050865](http://purl.obolibrary.org/obo/GO_0050865) (regulation of cell activation) 52.94%
- [GO:0002429](http://purl.obolibrary.org/obo/GO_0002429) (immune response-activating cell surface receptor signaling pathway) and [GO:0048522](http://purl.obolibrary.org/obo/GO_0048522) (positive regulation of cellular process) 52.94%
- [GO:0002429](http://purl.obolibrary.org/obo/GO_0002429) (immune response-activating cell surface receptor signaling pathway) and [GO:0038095](http://purl.obolibrary.org/obo/GO_0038095) (Fc-epsilon receptor signaling pathway) 52.94%
- [GO:0002429](http://purl.obolibrary.org/obo/GO_0002429) (immune response-activating cell surface receptor signaling pathway) and [GO:0033005](http://purl.obolibrary.org/obo/GO_0033005) (positive regulation of mast cell activation) 52.94%


